Summary
We have qualitatively evaluated the retention of the fluorescent dye rhodamine 123 by malignant or non-malignant breast epithelial cells in passively-infused fresh surgical specimens. Our findings demonstrate a microscopically-visible increase in the ability of primary and metastatic tumor cells to retain the dye, as compared to non-malignant epithelium. Some variability in fluorescence intensity was seen within and between tumor specimens. The optimal length of incubation in the presence of the dye was critical in achieving differential fluorescence intensity between normal and malignant cells. This method of examining rhodamine 123 uptake and retention in tissue explants provides a reliable means for direct, comparative visualizationin situ of any tissue and its associated disorders. The results of this study also demonstrate the validity of extending the use of liophilic, cationic compounds such as rhodamine 123 as antitumor agents, from model systems to the treatment of malignant disease.
This is a preview of subscription content, log in via an institution to check access.
References
Johnson LV, Walsh ML, Chen LB: Localization of mitochondria in living cells with rhodamine 123. Proc Natl Acad Sci USA 77: 990–994, 1980
Chen LB, Summerhayes IC, Johnson LV, Walsh ML, Bernal SD, Lampidis TJ: Probing mitochondria in living cells with rhodamine 123. Cold Spring Harbor Symp Quant Biol 46: 141–155, 1982
Summerhayes IC, Lampidis TJ, Bernal SD, Nadakavukaren JJ, Nadakavukaren KK, Shepherd EL, Chen LB: Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. Proc Natl Acad Sci USA 79: 5292–5296, 1982
Lampidis TJ, Bernal SD, Summerhayes IC, Chen LB: Selective toxicity of rhodamine 123 in carcinoma cellsin vitro. Cancer Res 43: 716–720, 1983
Bernal SD, Lampidis TJ, McIsaac RM, Chen LB: Anticarcinoma activityin vivo of rhodamine 123, a mitochondrial-specific dye. Science 222: 169–172, 1983
Davis S, Weiss MJ, Wong JR, Lampidis TJ, Chen LB: Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J Biol Chem 260: 13844–13850, 1985
Dairkee SH, Hackett AJ: Internal antigens accessible in breast cancer: implications for tumor targeting. J Natl Cancer Inst 80: 1216–1220, 1988
Smith HS, Dairkee SH, Ljung BM, Mayall B, Sylvester SS, Hackett AJ: Cellular manifestations of human breast cancer. In: Medina K, Kidwell W, Heppner G, Anderson E (eds) Cellular and Molecular Biology of Mammary Cancer. Plenum Publishing Corporation, New York, 1987, pp 437–452
Band V, Sager R: Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad Sci USA 86: 1249–1253, 1989
Beckman WD, Powers SK, Brown T, Gillespie GY, Bigner DD, Camps JL: Differential retention of rhodamine 123 by avian sarcoma virus-induced glioma and normal brain tissue of the ratin vivo. Cancer 59: 266–270, 1987
Bernal SD, Shapiro HM, Chen LB: Monitoring the effect of anticancer drugs on L1210 cells by a mitochondrial probe, rhodamine 123. Int J Cancer 30: 219–224, 1982
Chen LB: Mitochondria as a reservoir for anticarcinoma drugs. Anticancer Drugs 191: 21–28, 1989
Goffney WH, Wong JH, Kern DH, Chase D, Krag DN, Storm FK:In vitro andin vivo cytotoxicity of rhodamine 123 combined with hyperthermia. Cancer Res 50: 459–463, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dairkee, S.H., Hackett, A.J. Differential retention of rhodamine 123 by breast carcinoma and normal human mammary tissue. Breast Cancer Res Tr 18, 57–61 (1991). https://doi.org/10.1007/BF01975444
Issue Date:
DOI: https://doi.org/10.1007/BF01975444